CMS FDA launch pathway expedites Medicare coverage for breakthrough medical devices, enabling payment within two months of FDA authorization.

The CMS 2026 Prior Authorization Rule, effective January 2026, mandates payers in Medicare Advantage, Medicaid, CHIP, and ACA markets to adopt FHIR-based APIs, electronic prior authorization, and ...

The Trump administration is delaying a voluntary model that aimed to expand access to GLP-1s in Part D after pushback from ...

The pathway is designed to reduce the delay between FDA authorization and Medicare coverage for certain Class II and Class ...

Federal regulators are proposing a new, faster Medicare coverage pathway for medical devices deemed by the FDA as ...

Including continuous glucose monitors (CGMs) and insulin pumps in the next round of Medicare’s competitive bidding program ...

Certain breakthrough-designated medical devices that receive market authorization will become eligible for Medicare coverage ...

The Centers for Medicare & Medicaid Services announced in a memo April 21that it is delaying implementation of the Medicare ...

A new proposed rule from the Centers for Medicare and Medicaid Services would reduce the required response time to Medicare ...